SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects
SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Type 2 diabetes mellitus is a chronic metabolic disease associated with high cardiovascular (CV) risk. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are the latest class of antidiabetic medication that inhibit the absorption of glucose from the proximal tubule of the kidney and hence cause glycosuria. Four SGLT2i are currently commercially av...
Alternative Titles
Full title
SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6720282
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6720282
Other Identifiers
ISSN
1660-4601,1661-7827
E-ISSN
1660-4601
DOI
10.3390/ijerph16162965
